Provided by Tiger Fintech (Singapore) Pte. Ltd.

AngioDynamics

9.58
+0.06000.63%
Pre-market: 10.000.4200+4.38%08:31 EDT
Volume:186.76K
Turnover:1.78M
Market Cap:389.01M
PE:-9.42
High:9.62
Open:9.52
Low:9.39
Close:9.52
Loading ...

Crude Oil Down 1%; US Weekly Jobless Claims Decline

Benzinga
·
09 Jan

BUZZ-AngioDynamics rises after forecasting smaller loss for 2025

Reuters
·
09 Jan

AngioDynamics Shares Rise 34.5% After Co Forecasts Narrower FY25 Loss per Share

THOMSON REUTERS
·
08 Jan

AngioDynamics Inc reports results for the quarter ended November 30 - Earnings Summary

Reuters
·
08 Jan

AngioDynamics Hosts Virtual NanoKnife Investor Event

TIPRANKS
·
08 Jan

AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates

Zacks
·
08 Jan

AngioDynamics Reports Growth and Advances NanoKnife System

TIPRANKS
·
08 Jan

AngioDynamics 2Q Loss Narrows, Revises FY25 Outlook

Dow Jones
·
08 Jan

AngioDynamics raises FY25 adjusted EBITDA view to $1M-$3M from ($2.5M)-$0

TIPRANKS
·
08 Jan

AngioDynamics: Fiscal Q2 Earnings Snapshot

Associated Press Finance
·
08 Jan

AngioDynamics Expects 2025 Adjusted EPS Loss Of $0.34 to $0.38 Compared To Prior Guidance Of $0.38-$0.42 And Consensus Of $0.40

Benzinga
·
08 Jan

AngioDynamics reports Q2 adjusted EPS (4c), consensus (11c)

TIPRANKS
·
08 Jan

AngioDynamics Continues To Expect 2025 Net Sales Of $282M-$288M, Representing Growth Of Between 4.2%–6.4% Over Fiscal 2024 Pro Forma Revenue Of $270.7M Versus Consensus Of $283.86M

Benzinga
·
08 Jan

AngioDynamics raises FY25 adjusted EPS view to (38c)-(34c) from (42c)-(38)

TIPRANKS
·
08 Jan

AngioDynamics Q2 2025 Adj EPS $(0.04) Beats $(0.11) Estimate, Sales $73.02M Beat $70.93M Estimate

Benzinga
·
08 Jan

AngioDynamics Inc Outlook FY25 Adjusted Loss per Share in Range of $0.34 to $0.38

THOMSON REUTERS
·
08 Jan

BRIEF-AngioDynamics Q2 Adjusted EPS USD -0.04

Reuters
·
08 Jan

AngioDynamics Q2 Adjusted Net Income USD -1.7 Million

THOMSON REUTERS
·
08 Jan

AngioDynamics Q2 Gross Margin 54.8%

THOMSON REUTERS
·
08 Jan

Press Release: AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

Dow Jones
·
08 Jan